Impact of Nerve-sparing Radical Hysterectomy on Patients' Urinary Dynamics
1 other identifier
interventional
120
0 countries
N/A
Brief Summary
Background: Radical hysterectomy is an important therapy for early cervical cancer. Disfunction of urinary dynamics is the most common postoperative adverse effects, which had negative impact on patients' quality of life. Nerve sparing radical hysterectomy (NSRH) could reserve inferior hypogastric plexus (IHP) innervating bladder, hence improving postoperative urinary dynamics. Furthermore impact of different energy instruments on urinary dynamic isn't clear. Objectives: This study is to compare urinary dynamics before and after NSRH, and to analyze the difference between BiClamp forcep (BiClamp® forcep, ERBE Elektromedizin, GmbH, Tuebingen, Germany) and water jet (ERBEJET®2) about the effects of dissecting IHP. Study population: Cervical cancer of FIGO IB stage, among which 120 cases are enrolled to randomly allocated to BiClamp group or water jet group. Intervention: Patients accept NSRH which all will be accomplished by Professor Ming Wu. Methods: All surgical patients are accessed via urinary dynamics before and four months after NSRH. On the 14th day after surgeries, urinary catheter will be removed and residual urine volume (RUV) will be measured. For patients of RUV \> 100 ml, urinary catheter will be replaced. Primary study endpoint: the successful rate of removing urinary catheter on the 14th day after NSRH. Secondary study endpoint: urinary dynamics four months after NSRH.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2013
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 11, 2017
CompletedFirst Posted
Study publicly available on registry
January 13, 2017
CompletedJanuary 13, 2017
January 1, 2017
3 years
January 11, 2017
January 12, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
successful rate of removing urinary catheter
successful rate (%) of removing urinary catheter assessed by residual urine volume less than 100 ml
14th day after nerve-sparing radical hysterectomy
Secondary Outcomes (8)
urinary dynamics parameters determined by urodynamics apparatus: bladder capacity and sensation
four months after nerve-sparing radical hysterectomy
urinary dynamics parameters determined by urodynamics apparatus: residual urine volume
four months after nerve-sparing radical hysterectomy
urinary dynamics parameters determined by urodynamics apparatus: urine flow rate
four months after nerve-sparing radical hysterectomy
urinary dynamics parameters determined by urodynamics apparatus: bladder pressure
four months after nerve-sparing radical hysterectomy
urinary dynamics parameters determined by urodynamics apparatus: detrusor pressure
four months after nerve-sparing radical hysterectomy
- +3 more secondary outcomes
Study Arms (2)
BiClamp group
PLACEBO COMPARATORBiClamp forcep (BiClamp® forcep, ERBE Elektromedizin, GmbH, Tuebingen, Germany) is used to dissect inferior hypogastric plexus
water jet group
ACTIVE COMPARATORwater jet (ERBEJET®2, ERBE Elektromedizin, GmbH, Tuebingen, Germany) is used to dissect inferior hypogastric plexus
Interventions
electric energy
water jet energy
Eligibility Criteria
You may qualify if:
- FIGO stage IB
- ASA score 0-2
You may not qualify if:
- Radiotherapy or chemotherapy before surgeries
- ASA score \> 2
- With abnormal urinary dynamics before surgeries
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wu Ming, MD
Peking Union Medical College Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 11, 2017
First Posted
January 13, 2017
Study Start
January 1, 2013
Primary Completion
January 1, 2016
Study Completion
January 1, 2017
Last Updated
January 13, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will share
IPD will be shared with authorised researchers via online database.